Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
European Heart Journal. Cardiovascular Pharmacotherapy|January 7, 2021
Effects of intensive urate lowering therapy with febuxostat in comparison with allopurinol on pulse wave velocity in patients with gout and increased cardiovascular risk: the FORWARD studyGiovambattista Desideri, Marek Rajzer, Martijn Gerritsen, et al.
Acta Orthopaedica|February 24, 2009
Dutch orthopedic thromboprophylaxis: a 5-year follow-up surveyHarmen B Ettema, Marieke C Mulder, Michael T Nurmohamed, et al.
RMD Open|February 5, 2022
Effectiveness of electronic drug monitoring feedback to increase adherence in patients with RA initiating a biological DMARD: a randomised clinical trialRenske Cf Hebing, Iremnur Aksu, Jos Wr Twisk, et al.
Annals of the Rheumatic Diseases|May 17, 2012
HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximabHennie G Raterman, Han Levels, Alexandre E Voskuyl, et al.
Clinical and Experimental Rheumatology|March 5, 2021
Interferon regulatory factor 5 gene variants rs2004640 and rs4728142 are associated with carotid intima media thickness but not with cardiovascular events in rheumatoid arthritisRabia Agca, Alper M van Sijl, Saskia Vosslamber, et al.
Annals of the Rheumatic Diseases|April 26, 2012
Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic reviewAnna Jamnitski, Deborah Symmons, Mike J L Peters, et al.
Rheumatology International|October 22, 2022
Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patientsAnnelies B Blanken, Reinder Raadsen, Rabia Agca, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 29, 2022
Probability of Medication Intensifications in Rheumatoid Arthritis Patients With Low Disease Activity Scores on Their Patient-Reported Outcomes: A Medical-Records Review StudyBart Fabian Seppen, Simone J Verkleij, Jimmy Wiegel, et al.
Arthritis Research & Therapy|September 21, 2006
Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control studyVokko P van Halm, Michael T Nurmohamed, Jos W R Twisk, et al.
Joint Bone Spine|December 31, 2023
Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative studyReinder Raadsen, Bas Dijkshoorn, Laurette van Boheemen, et al.
Pageof 18